Impact of high neutrophil-to-lymphocyte ratio on the cardiovascular benefit of PCSK9 inhibitors in familial hypercholesterolemia subjects with atherosclerotic cardiovascular disease: Real-world data from two lipid units
Roberto Scicali, Giuseppe Mandraffino, Antonino Di Pino, Michele Scuruchi, Viviana Ferrara, Giovanni Squadrito, Francesco Purrello, Salvatore Piro
Topics & Concepts
PCSK9MedicineInternal medicineFamilial hypercholesterolemiaPulse wave velocityPopulationNeutrophil to lymphocyte ratioBiomarkerGastroenterologyEvolocumabApolipoprotein BEzetimibeCardiologyEndocrinologyLymphocyteCholesterolLipoproteinLDL receptorBlood pressureApolipoprotein A1BiologyBiochemistryEnvironmental healthLipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular DiseasesCardiovascular Health and Disease Prevention